Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APVO | AMGN | BMY | VRTX | GILD |
| Company | Aptevo Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.2867 | 289.84 | 58.32 | 452.99 | 89.67 |
| High | 0.2888 | 290.34 | 58.35 | 456.14 | 90.06 |
| Low | 0.2750 | 289.07 | 57.63 | 450.00 | 89.48 |
| Last | 0.2700 | 291.26 | 58.08 | 453.94 | 89.76 |
| Change | +0.0032 | +1.36 | -0.15 | +3.57 | -0.28 |
| % Change | +1.20% | +0.47% | -0.26% | +0.79% | -0.31% |
| Volume | 290,869 | 13,633 | 279,590 | 13,290 | 45,079 |
| 20-Day Average Volume | 3,025,938 | 2,843,317 | 12,055,979 | 1,295,464 | 7,244,649 |
| Previous Close | 0.2668 | 289.90 | 58.23 | 450.37 | 89.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2644 | 306.06 | 56.21 | 477.85 | 90.91 |
| 20-Day Raw Stochastic | 48.18% | 27.22% | 63.18% | 6.68% | 26.52% |
| 20-Day Relative Strength | 52.24% | 36.50% | 58.75% | 40.78% | 52.87% |
| Weighted Alpha | -76.31 | +1.92 | +24.38 | +17.92 | +25.53 |
| Today's Opinion | 40% Sell | 40% Sell | 100% Buy | 24% Sell | 80% Buy |
| Previous Opinion | 40% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 72% Sell | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +30.33% since 11/15/24 | +2.22% since 11/15/24 | +2.57% since 11/15/24 | -3.37% since 11/15/24 | +1.22% since 11/15/24 |
| Low | 0.2022 on 11/18/24 | 275.56 on 11/19/24 | 55.84 on 11/18/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 0.3255 on 11/20/24 | 291.11 on 11/21/24 | 58.83 on 11/20/24 | 468.88 on 11/18/24 | 90.06 on 11/22/24 |
| 1-Month | |||||
| %Chg | -22.23% since 10/22/24 | -9.31% since 10/22/24 | +9.30% since 10/22/24 | -5.25% since 10/22/24 | +1.50% since 10/22/24 |
| Low | 0.2022 on 11/18/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 0.3533 on 10/29/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -27.75% since 08/22/24 | -10.67% since 08/22/24 | +21.10% since 08/22/24 | -6.23% since 08/22/24 | +17.89% since 08/22/24 |
| Low | 0.1380 on 10/14/24 | 275.56 on 11/19/24 | 47.38 on 08/23/24 | 445.00 on 11/21/24 | 75.91 on 08/23/24 |
| High | 0.5150 on 10/22/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -63.38% since 05/22/24 | -6.31% since 05/22/24 | +36.20% since 05/22/24 | +0.55% since 05/22/24 | +31.98% since 05/22/24 |
| Low | 0.1380 on 10/14/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 0.8900 on 06/10/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,939 | 155,830,816 | 118,100,752 | 115,983,328 | 111,864,840 |
| Shares Outstanding, K | 18,512 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -17,410,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -5,100,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 5.07 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.48 on 11/07/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.98 | 49.47 | 0.00 | 20.01 |